Related Experiment Videos
Thromboembolic complications in coronary angiography. Prevention with acetyl-salicylic acid
Acta Radiologica: Diagnosis
|September 1, 1977
Insights
Acetyl-salicylic acid (aspirin) did not significantly alter fatality rates during coronary angiography. However, prophylactic aspirin administration significantly reduced the incidence of cerebral emboli, suggesting a benefit in preventing specific thromboembolic complications.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Thromboembolic complications pose a risk during coronary angiography.
- Acetyl-salicylic acid is a widely used antiplatelet agent.
Purpose of the Study:
- To evaluate the efficacy of acetyl-salicylic acid in preventing thromboembolic complications during coronary angiography.
- To assess the impact of acetyl-salicylic acid on fatality rates and cerebral emboli.
Main Methods:
- Retrospective analysis of patients undergoing coronary angiography.
- Comparison of outcomes between patients who received acetyl-salicylic acid prophylactically and those who did not.
Main Results:
- No significant difference in fatality rates was observed between the two groups.
- A statistically significant reduction in cerebral emboli was noted in patients receiving prophylactic acetyl-salicylic acid.
Conclusions:
- Prophylactic acetyl-salicylic acid may be beneficial in reducing cerebral embolic events in patients undergoing coronary angiography.
- Further research may be warranted to confirm these findings and optimize its use.
Abstract:
The effect of acetyl-salicylic acid to prevent thromboembolic complications in coronary angiography is reported. No significant difference in fatality rate between the period without and the period with acetyl-salicylic acid was found but significantly less cerebral emboli when acetyl-salicylic acid was given prophylactically.